Participants in the ASK program who test positive for islet autoantibodies and are having abnormal blood glucose testing are invited to participate in the TESS intervention study.

TESS.png

The Early Start Study (TESS) is an intervention study — conducted by the Barbara Davis Center for Diabetes at the University of Colorado Anschutz Medical Campus — to determine the best education and monitoring strategy for children/youth (ages 2-20 years) with pre-symptomatic type 1 diabetes (T1D).

 

The TESS study uses continuous glucose monitor (CGM) technology and staged education with a diabetes specialty team to teach families about changes in blood sugars in the lead up to symptomatic T1D. This will also allow careful monitoring and recognition of the need for insulin. The overall goal is to maintain blood sugars in target range and reduce the risk of life-threatening DKA at diagnosis.

CONTACT:  TESS.study@CUAnschutz.edu

brigittefrohnert.jpeg

Brigitte Frohnert, MD, PhD
Associate Professor,
Pediatric Diabetes Division,

Barbara Davis Center for Diabetes

View profile  |  Clinical publications
 

Principal Investigator, TESS

Flor-RB.jpg

Flor Sepulveda

Sr. Professional Research Assistant, Pediatrics-Endocrinology,
Barbara Davis Center for Diabetes

Program Manager, TESS

Screen Shot 2021-10-06 at 4.10.58 PM.png

View Dr. Frohnert's "Treatment of Early-Diagnosed T1D" presentation from the “Practical Ways to Achieve Targets in Diabetes Care” (virtual) ATDC Conference (July 15-18, 2021)